Genetic variations in UDP-glucuronosyl transferase 2B17: implications for testosterone excretion profiling and doping control programs.
Starcevic
Borislav
B
UCLA Olympic Analytical Laboratory, Department of Pathology & Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90025-6106, USA.
Butch
Anthony W
AW
D045930:Anabolic Agents / Q000378:metabolism; D004300:Doping in Sports / Q000208:ethnology; D005260:Female; D014453:Glucuronosyltransferase / Q000235:genetics*; D006801:Humans; D008297:Male; D015778:Minor Histocompatibility Antigens; D011110:Polymorphism, Genetic; D044469:Racial Groups; D015813:Substance Abuse Detection / Q000379:methods* / Q000592:standards; D013739:Testosterone / Q000031:analogs & derivatives* / Q000378:metabolism / Q000652:urine; D045165:Testosterone Congeners / Q000378:metabolism
D045930:Anabolic Agents; D015778:Minor Histocompatibility Antigens; D045165:Testosterone Congeners; C015529:testosterone glucuronate; D013739:Testosterone; D014453:Glucuronosyltransferase; C500513:UGT2B17 protein, human